Clinical Trial Update: Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov notes a pediatric pharmacokinetics, safety, and tolerability study of the dolutegravir/rilpivirine regimen (Phase 1/Phase 2), currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)
• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1, Phase 2 | Status: RECRUITING